Skip to main content
    P

    PTC Therapeutics Inc (PTCT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $60.36
    -0.61 (-1.00%)

    Market Cap: $5.09B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    PTC Therapeutics Inc (PTCT) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    PTC Therapeutics (PTCT) has a latest price of $60.36 on Nov 17, 2026, 33.6% below its 52-week high of $90.87. Its price fell 19.8% over the past 12 months. The month-end price rose 865.7% over the 10 years through Oct 2026, a compound annual rate of 25.5%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $85.99 in Nov 2025 and its lowest $6.21 in Oct 2016, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart PTCT with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PTCT.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 18.1%, and over 6 months it fell 14.2%. The month-end price rose 219.8% over the 3 years through Oct 2026, a compound annual rate of 47.3%.

    PeriodChange
    1 month-1.9%
    3 months-18.1%
    6 months-14.2%
    12 months-19.8%
    12 months, with dividends-19.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+219.8%+47.3%
    5 years+58.1%+9.6%
    10 years+865.7%+25.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2018, when the price rose 105.8%, and its weakest was 2021, when it fell 34.7%.

    YearCloseChange
    2026 through Oct 2026$59.97-21.1%
    2025$75.96+68.3%
    2024$45.14+63.8%
    2023$27.56-27.8%
    2022$38.17-4.2%
    2021$39.83-34.7%
    2020$61.03+27.1%
    2019$48.03+39.9%
    2018$34.32+105.8%
    2017$16.68+52.9%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 5.4% below its 50-day average of $63.78 and 13.8% below its 200-day average of $70.02.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$60.36
    52-week high$90.87-33.6%
    52-week low$58.80+2.7%
    50-day average$63.78-5.4%
    200-day average$70.02-13.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 36.7%.

    MeasureValue
    1-year beta0.86
    Largest fall, 1 year-33.8%
    Largest fall, 3 years-36.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About PTCT

    What is PTCT's 1-year price change?

    PTC Therapeutics's price fell 19.8% over the past 12 months. With dividends included, the 12-month total return was -19.8%.

    What is PTCT's 5-year price change?

    PTC Therapeutics's month-end price rose 58.1% over the 5 years through Oct 2026, a compound annual rate of 9.6%. These figures leave out dividends.

    What is PTCT's 52-week high and low?

    PTC Therapeutics's 52-week high is $90.87 and its 52-week low is $58.80. Its latest price of $60.36 on Nov 17, 2026 is 33.6% below the high.

    What is PTCT's beta?

    PTC Therapeutics's 1-year beta against the S&P 500 is 0.86, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 33.8%.

    Is the PTCT chart free?

    Yes. Advanced Charting for PTCT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.